Login / Signup
Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria.
Kittiphan Chienwichai
Phirada Chaloemwa
Sorawat Sangkaew
Arunchai Chang
Published in:
Clinical nephrology (2024)
ACEi/ARB therapy was suboptimal in patients with diabetes, hypertension, and albuminuria. Non-adherence was associated with CKD stage, possibly because of concerns about adverse events and healthcare-related factors.
Keyphrases
</>
angiotensin converting enzyme
angiotensin ii
healthcare
vascular smooth muscle cells
blood pressure
chronic kidney disease
type diabetes
metabolic syndrome
binding protein
stem cells
mesenchymal stem cells
cell therapy
health insurance